Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: The Lifestyle Exercise and Diet Trial (LEAD) 2.0 [NA]

View source ↗

Summary

The LEAD 2.0 lifestyle exercise and diet trial conducted by the University of Waterloo for Subjective Cognitive Decline is currently listed as active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Waterloo | Conditions: Subjective Cognitive Decline | NA | Status: ACTIVE_NOT_RECRUITING